New Market Report: MDxHealth SA (MDXH) - Product Pipeline Analysis, 2013 Update
MdxHealth SA (MdxHealth), formerly OncoMethylome Sciences SA, is a molecular diagnostics company. It develops and commercializes advanced molecular diagnostic tests for the early detection of cancer and personalized treatment decisions. It focuses on three different types of cancers, namely, prostate cancer, colorectal cancer and lung cancer. The company's tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also provides indications of cancer recurrence and prediction of response to a specific therapy....
View full press release